Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

First Affiliated Hospital Of Guangxi Medical University

Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.

Trials to join now! 2 Not yet recruiting 7 Not yet finished but already full! 1 Terminated 1

Immunotherapy-Chemo cocktail targets tough colon cancer before surgery

Disease control Ongoing

This phase 2 trial is testing whether adding the immunotherapy drug tislelizumab to standard chemotherapy (oxaliplatin and capecitabine) before surgery can help shrink tumors in people with a specific type of locally advanced colon cancer called microsatellite stable (MSS). About…

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC